Evidence map›Paper›PMID 34173207›Full record

ArticleProbiotics and antimicrobial proteins2021

Bacteriocin-Like Inhibitory Substance (BLIS) Activity of Enterococcus faecium DB1 Against Biofilm Formation by Clostridium perfringens.

Ji Soo Lee, Sun Woo Park, Han Bin Lee, Seok-Seong Kang

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Probiotic potential ofVeterinary world · 2026
    Article
  5. Extracellular vesicles fromCurrent research in food science · 2025
    Article
  6. Article
  7. Article
  8. Screening of bacteriocin-producing dairyFrontiers in microbiology · 2023
    Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ji Soo LeeDepartment of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University, Goyang, 10326, Republic of Korea.
Sun Woo ParkDepartment of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University, Goyang, 10326, Republic of Korea.
Han Bin LeeDepartment of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University, Goyang, 10326, Republic of Korea.
Seok-Seong KangDepartment of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University, Goyang, 10326, Republic of Korea. sskang@dongguk.edu.ORCID 0000-0001-7029-9122
Dongguk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antibiofilm effect of bacteriocin-like inhibitory substance (BLIS) from Enterococcus faecium DB1 against Clostridium perfringens was investigated in the present study. BLIS of E. faecium DB1 significantly reduced biofilm formation by C. perfringens in a dose-dependent manner for 24 and 48 h. In particular, treatment with BLIS of E. faecium DB1 significantly inhibited biofilm formation by C. perfringens on chicken meat and stainless steel coupon surfaces. Moreover, BLIS of E. faecium DB1 decreased the viability of C. perfringens biofilm and planktonic cells, indicating that the reduction of biofilm formation by C. perfringens might be achieved by killing the bacterial cells. Taken together, the present results suggest that BLIS of E. faecium DB1 can be a promising antibiofilm agent to eradicate C. perfringens.

Indexed as

BacteriocinsEnterococcus faeciumBiofilmsClostridium perfringensBacteriocinsAntibiofilm agentBacteriocin-like inhibitory substanceBiofilmClostridium perfringensEnterococcus faecium

Identifiers

PMID34173207
OpenAlexW3174206263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.